Sonja Vermeren

Jun 2, 2024 | biorxiv.org | Katie Smith |Zachary Lim |Sonja Vermeren |Veronique Miron

AbstractMultiple Sclerosis (MS) is a complex auto-inflammatory disease affecting the brain and spinal cord, which results in axonal de-myelination and symptoms including fatigue, pain, and difficulties with vision and mobility. The involvement of the immune system in the pathology of MS is well established, particularly the adaptive T cell response, and there has been a particular focus on the IL-17-producing subset of Th17 cells and their role in driving disease.

Jun 2, 2024 | biorxiv.org | Katie Smith |Zachary Lim |Sonja Vermeren |Veronique Miron

AbstractMultiple Sclerosis (MS) is a complex auto-inflammatory disease affecting the brain and spinal cord, which results in axonal de-myelination and symptoms including fatigue, pain, and difficulties with vision and mobility. The involvement of the immune system in the pathology of MS is well established, particularly the adaptive T cell response, and there has been a particular focus on the IL-17-producing subset of Th17 cells and their role in driving disease.

Jun 2, 2024 | biorxiv.org | Katie Smith |Zachary Lim |Sonja Vermeren |Veronique Miron

AbstractMultiple Sclerosis (MS) is a complex auto-inflammatory disease affecting the brain and spinal cord, which results in axonal de-myelination and symptoms including fatigue, pain, and difficulties with vision and mobility. The involvement of the immune system in the pathology of MS is well established, particularly the adaptive T cell response, and there has been a particular focus on the IL-17-producing subset of Th17 cells and their role in driving disease.